Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan.
Nakano Y, Kurano M, Morita Y, Shimura T, Yokoyama R, Qian C, Xia F, He F, Kishi Y, Okada J, Yoshikawa N, Nagura Y, Okazaki H, Moriya K, Seto Y, Kodama T, Yatomi Y.
Nakano Y, et al. Among authors: kishi y.
Sci Rep. 2021 Feb 2;11(1):2776. doi: 10.1038/s41598-021-82428-5.
Sci Rep. 2021.
PMID: 33531605
Free PMC article.